<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A small population of CD55(-)CD59(-) blood cells was detected in a patient who developed donor-type late graft failure after allogeneic stem cell transplantation (SCT) for treatment of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA) </plain></SENT>
<SENT sid="1" pm="."><plain>Chimerism and PIGA gene analyses showed the <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>)-type granulocytes to be of a donor-derived stem cell with a <z:chebi fb="2" ids="17821">thymine</z:chebi> insertion in PIGA exon 2 </plain></SENT>
<SENT sid="2" pm="."><plain>A sensitive mutation-specific polymerase chain reaction (PCR)-based analysis detected the mutation exclusively in DNA derived from the donor bone marrow (BM) cells </plain></SENT>
<SENT sid="3" pm="."><plain>The patient responded to immunosuppressive therapy and achieved transfusion independence </plain></SENT>
<SENT sid="4" pm="."><plain>The small population of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-type cells was undetectable in any of the 50 SCT recipients showing stable engraftment </plain></SENT>
<SENT sid="5" pm="."><plain>The de novo development of donor cell-derived AA with a small population of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-type cells in this patient supports the concept that glycosyl phosphatidylinositol-anchored protein-deficient stem cells have a survival advantage in the setting of immune-mediated BM injury </plain></SENT>
</text></document>